KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) Equity Average (2016 - 2025)

Historic Equity Average for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $50.8 billion.

  • Thermo Fisher Scientific's Equity Average rose 533.76% to $50.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $50.8 billion, marking a year-over-year increase of 533.76%. This contributed to the annual value of $48.2 billion for FY2024, which is 611.68% up from last year.
  • Per Thermo Fisher Scientific's latest filing, its Equity Average stood at $50.8 billion for Q3 2025, which was up 533.76% from $50.0 billion recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Equity Average peaked at $50.8 billion during Q3 2025, and registered a low of $34.8 billion during Q2 2021.
  • In the last 5 years, Thermo Fisher Scientific's Equity Average had a median value of $43.8 billion in 2022 and averaged $43.9 billion.
  • Its Equity Average has fluctuated over the past 5 years, first surged by 2306.53% in 2021, then skyrocketed by 328.65% in 2023.
  • Thermo Fisher Scientific's Equity Average (Quarter) stood at $39.8 billion in 2021, then grew by 10.15% to $43.8 billion in 2022, then rose by 5.07% to $46.0 billion in 2023, then grew by 7.03% to $49.3 billion in 2024, then rose by 3.02% to $50.8 billion in 2025.
  • Its last three reported values are $50.8 billion in Q3 2025, $50.0 billion for Q2 2025, and $49.5 billion during Q1 2025.